Patents by Inventor Hiren PANSURIYA
Hiren PANSURIYA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12186322Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: GrantFiled: May 16, 2024Date of Patent: January 7, 2025Assignee: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
-
Patent number: 12186321Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: GrantFiled: April 4, 2024Date of Patent: January 7, 2025Assignee: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
-
Publication number: 20240299396Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: ApplicationFiled: May 16, 2024Publication date: September 12, 2024Applicant: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
-
Publication number: 20240245689Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: ApplicationFiled: April 4, 2024Publication date: July 25, 2024Applicant: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
-
Publication number: 20240245688Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: ApplicationFiled: April 2, 2024Publication date: July 25, 2024Applicant: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
-
Patent number: 12005062Abstract: The present disclosure is directed to pharmaceutical compositions comprising sildenafil or a pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of sildenafil or a pharmaceutically acceptable salt thereof such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: GrantFiled: August 4, 2023Date of Patent: June 11, 2024Assignee: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
-
Patent number: 11975006Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: GrantFiled: April 28, 2023Date of Patent: May 7, 2024Assignee: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
-
Publication number: 20230381187Abstract: The present disclosure is directed to pharmaceutical compositions comprising sildenafil or a pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of sildenafil or a pharmaceutically acceptable salt thereof such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: ApplicationFiled: August 4, 2023Publication date: November 30, 2023Applicant: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
-
Patent number: 11759468Abstract: The present disclosure is directed to pharmaceutical compositions comprising sildenafil or a pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of sildenafil or a pharmaceutically acceptable salt thereof such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: GrantFiled: August 31, 2022Date of Patent: September 19, 2023Assignee: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
-
Publication number: 20230285398Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: ApplicationFiled: April 28, 2023Publication date: September 14, 2023Applicant: LiqMeds Worldwide LimitedInventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
-
Patent number: 11666576Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: GrantFiled: June 6, 2022Date of Patent: June 6, 2023Assignee: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
-
Publication number: 20220409621Abstract: The present disclosure is directed to pharmaceutical compositions comprising sildenafil or a pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of sildenafil or a pharmaceutically acceptable salt thereof such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: ApplicationFiled: August 31, 2022Publication date: December 29, 2022Applicant: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
-
Patent number: 11464778Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: GrantFiled: December 24, 2018Date of Patent: October 11, 2022Assignee: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
-
Publication number: 20220296602Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: ApplicationFiled: June 6, 2022Publication date: September 22, 2022Inventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
-
Patent number: 11382917Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: GrantFiled: August 16, 2021Date of Patent: July 12, 2022Assignee: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
-
Patent number: 11337979Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: GrantFiled: August 16, 2021Date of Patent: May 24, 2022Assignee: LIQMEDS WORLDWIDE LIMITEDInventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
-
Publication number: 20210393635Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: ApplicationFiled: August 16, 2021Publication date: December 23, 2021Inventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
-
Publication number: 20210369717Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: ApplicationFiled: August 16, 2021Publication date: December 2, 2021Inventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
-
Publication number: 20210052591Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.Type: ApplicationFiled: December 24, 2018Publication date: February 25, 2021Inventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA